RR
Robert Richard Ruffolo
About Robert Richard Ruffolo
Data last updated:
Robert Richard Ruffolo is a Director at Aragen Life Sciences Limited (since 2019) and Director at Aragen Biologics Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1,874 Cr; the largest is Aragen Life Sciences Limited at ₹1,870 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aragen Life Sciences Limited U74999TG2000PLC035826 | Director | 17 Apr 2019 | 2000 | ₹1,870 Cr (FY 2025) | Active |
 Aragen Biologics Private Limited U21001TS2023PTC174243 | Director | 03 Jul 2025 | 2023 | ₹3.37 Cr (FY 2025) | Active |
Board colleagues of Robert Richard Ruffolo
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Robert Richard Ruffolo
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Robert Richard Ruffolo
Robert Richard Ruffolo currently holds 2 directorships: Aragen Life Sciences Limited (Director, since 17 Apr 2019, revenue ₹1,870 Cr (FY 2025)); Aragen Biologics Private Limited (Director, since 03 Jul 2025, revenue ₹3.37 Cr (FY 2025)).
Robert Richard Ruffolo was first appointed on 17 Apr 2019 as Director at Aragen Life Sciences Limited. The most recent appointment on record is 03 Jul 2025 at Aragen Biologics Private Limited.
The 2 current companies of Robert Richard Ruffolo that report revenue have a combined latest revenue of ₹1,874 Cr: Aragen Life Sciences Limited ₹1,870 Cr (FY 2025); Aragen Biologics Private Limited ₹3.37 Cr (FY 2025).
The current boards of Robert Richard Ruffolo's companies include Ajay Srivastava (Aragen Life Sciences Limited), Amit Varma (Aragen Life Sciences Limited), Anita Ramachandran (Aragen Life Sciences Limited), Davinder Singh Brar (Aragen Life Sciences Limited), Gunapati Reddy Venkat Keshav (Aragen Life Sciences Limited), Manmahesh Kantipudi (Aragen Life Sciences Limited), among others.